Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q4 2023 ▲▼ | Q1 2024 ▲▼ | Change ▲▼ | Q4 2023 ▲▼ | Q1 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Dyne Therapeutics, Inc.(DYN) | 4,951,303 | 3,451,303 | -1,500,000 | 65,852 | 97,982 | 39.97% | +32,130 |
| Werewolf Therapeutics, Inc.(HOWL) | 4,284,172 | 4,284,172 | 0 | 16,537 | 27,761 | 11.32% | +11,225 |
| iTeos Therapeutics, Inc. | 2,738,785 | 2,738,785 | 0 | 29,990 | 37,357 | 15.24% | +7,367 |
| Adaptimmune Therapeutics plc(ADAPY) | 5,555,461 | 5,555,461 | 0 | 4,405 | 8,778 | 3.58% | +4,372 |
| Harpoon Therapeutics, Inc. | 313,136 | 0 | -313,136 | 3,560 | 0 | — | -3,560 |
| Entrada Therapeutics, Inc.(TRDA) | 4,425,784 | 4,425,784 | 0 | 66,785 | 62,713 | 25.58% | -4,072 |
| Repare Therapeutics, Inc. | 2,242,636 | 2,242,636 | 0 | 16,371 | 10,563 | 4.31% | -5,808 |